Skip to content

Neuropace, Inc. NPCE Interest Paid

Interest Paid at other companies

Medtronic logo
MedtronicMDT
$201M+3.1%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$525K
Inspire Medical Systems logo
Inspire Medical SystemsINSP
$16K
ARS Pharmaceuticals, Inc. logo
ARS Pharmaceuticals, Inc.SPRY
$2.29M
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$140K+35.9%
Stryker logo
StrykerSYK
$145.5M+47.0%

Other financials

Income statement

See full
Revenue$22.1M-2.0%
Gross profit$18.0M+4.1%
Operating income-$5.6M-8.2%
Net income-$6.7M-1.5%
EPS (diluted)-$0.20+4.8%

Balance sheet

See full
Cash & equivalents$15.6M-42.4%
Total debt$70.5M-3.7%
Total equity$14.5M-40.4%
Total assets$98.9M-10.3%

Cash flow

See full
Operating cash flow-$5.9M+21.1%
CapEx$117.0K+216%
Free cash flow-$6.0M+20.0%

Valuation

See full
Market cap$557.77M+63.4%
Enterprise value$612.6M+58.1%
P/S5.6×+1.6×

Profitability

See full
Gross margin78.3%+3.5pp
Operating margin-16.8%-3.5pp
Net margin-21.7%-4.5pp
FCF margin-10.3%-3.5pp

Returns & leverage

See full
Return on equity-111.4%-13.1pp
Debt / equity4.9×+1.9×
Current ratio5.4×-1.2×

Where this comes from

Reported directly by Neuropace, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuropace, Inc.'s interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuropace, Inc.'s interest paid?
Neuropace, Inc. (NPCE) reported interest paid of $1.39M in Q1 2026.
How has Neuropace, Inc.'s interest paid changed year-over-year?
Neuropace, Inc.'s interest paid decreased by 26.6% year-over-year, from $1.89M to $1.39M.
What is the long-term trend for Neuropace, Inc.'s interest paid?
Over 4 years (2021 to 2025), Neuropace, Inc.'s interest paid has grown at a -0.6% compound annual growth rate (CAGR), from $6.34M to $6.2M.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.